logo
Lead and Arsenic Discovered in Trusted Toothpaste Brands

Lead and Arsenic Discovered in Trusted Toothpaste Brands

Yahoo21-04-2025

That minty-fresh feeling might come with a hidden cost. A recent study has found that popular toothpaste brands are contaminated with dangerous heavy metals like lead and mercury, posing unexpected health risks every time you brush.
A new U.S. study has uncovered a disturbing truth about the products many rely on for daily oral care. The study discovered that popular toothpaste brands, including those marketed for children and as 'natural' or 'eco-friendly,' are contaminated with toxic heavy metals.
The investigation, led by consumer advocacy group Lead Safe Mama, tested 51 toothpaste products and found that approximately 90% contained lead. Even more concerning, 65% had traces of arsenic, nearly half tested positive for mercury, and about one-third showed cadmium contamination.
Many of these toothpastes contained multiple heavy metals, intensifying health concerns. While the highest detected levels violated safety standards set by Washington State, they still fell within federal limits—limits that public health experts argue are dangerously outdated and insufficient.
'It's unconscionable—especially in 2025,' said Tamara Rubin, founder of Lead Safe Mama. 'What's really interesting to me is that no one thought this was a concern.'
Despite proposed legislation like the stalled Baby Food Safety Act of 2024, which seeks to cap lead levels in children's food at 10 parts per billion (ppb), and California's stricter 6 ppb limit, no such regulations currently exist for toothpaste.
Rubin suggests the contamination may be linked to ingredients commonly found in toothpaste formulations like hydroxyapatite (often derived from cow bone), calcium carbonate, and bentonite clay. These substances are typically included for their whitening or cleansing properties and dental benefits, but may inadvertently introduce dangerous levels of heavy metals into the product.
Several well-known toothpaste brands—including Crest, Sensodyne, Tom's of Maine, Dr. Bronner's, Davids, and Dr. Jen—were flagged in the recent study for containing concerning levels of heavy metals. Despite the serious findings, none of the named companies have taken action to remove lead from their products, according to Tamara Rubin of Lead Safe Mama.
Rather than addressing the contamination, some companies responded with legal threats. Rubin revealed that she received cease-and-desist letters from certain manufacturers, which she publicly shared on her blog. In defense, some brands claimed that lead is naturally present in the environment and, therefore, impossible to eliminate entirely. Others dismissed the study's findings as insignificant or unworthy of concern.
Neither the U.S. Food and Drug Administration nor Procter & Gamble, the parent company of Crest, has issued a statement regarding the study.
On a more positive note, not all toothpaste brands tested showed contamination. Products such as Dr. Brown's Baby Toothpaste were found to be free from lead, mercury, arsenic, and cadmium. Notably, these safer options also avoided the three high-risk ingredients—hydroxyapatite, calcium carbonate, and bentonite clay—suggesting a potential link between formulation choices and contamination levels.
The presence of heavy metals in toothpaste poses serious health threats, especially for children. Lead exposure, even at low levels, can impair cognitive development, reduce IQ, and cause behavioral issues. It can also harm kidney function and raise the risk of heart disease over time.
Worryingly, all four metals detected in the study—lead, mercury, cadmium, and arsenic—are classified as carcinogens. Their presence in everyday hygiene products like toothpaste adds to growing concerns over long-term exposure and the cumulative effects on children's health and development.
Read the original article on GEEKSPIN. Affiliate links on GEEKSPIN may earn us and our partners a commission.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New Space-Based Research May Pave the Way for First Astronaut with Diabetes
New Space-Based Research May Pave the Way for First Astronaut with Diabetes

Yahoo

time5 days ago

  • Yahoo

New Space-Based Research May Pave the Way for First Astronaut with Diabetes

ISS National Lab-sponsored study launching on Axiom Mission 4 to advance diabetes management in space KENNEDY SPACE CENTER, Fla., June 3, 2025 /PRNewswire/ -- An investigation launching to the International Space Station (ISS) on Axiom Mission 4 (Ax-4) aims to advance diabetes management in microgravity and open access to space for more people. Researchers will demonstrate the accuracy of glucose monitoring and the viability of insulin on the ISS, with the long-term goal of supporting astronauts with insulin-dependent diabetes on future space missions. The ISS National Lab-sponsored project, Suite Ride, is a partnership between Axiom Space and Burjeel Holdings PLC, a healthcare services provider based in the United Arab Emirates. According to the International Diabetes Federation, one in nine adults worldwide—which amounts to nearly 590 million people—are living with diabetes. That number is expected to rise to more than 780 million people by 2045. "Individuals with insulin-dependent diabetes historically have been disqualified from flying to low Earth orbit," said Alex Rubin, medical operations group lead at Axiom Space. "A main objective of the study is to demonstrate that a condition such as this can be accurately monitored and treated in microgravity, with the intent of eventually flying a crew member with the condition." The team is sending several commercially available glucose monitors to the ISS to ensure they maintain a comparable level of accuracy in microgravity. One of the monitors samples interstitial fluid (the fluid filling the spaces between cells in the body) to measure glucose levels. Microgravity causes shifts in body fluids that could affect the accuracy of these devices. "We intend to demonstrate that the monitors can be relied upon, or if there is a difference due to microgravity, that it is something we can calibrate to and resolve," Rubin said. The study will also look at whether microgravity affects the integrity of insulin. Previous research showed that insulin pens can accurately administer doses during spaceflight. For this project, several different types of insulin will be sent to the ISS, with some stored at ambient or room temperature and some in cold stowage. The team will test the samples after they return to determine if microgravity had any effect. Results from this investigation could make it possible to support people with diabetes on future space missions, expanding the pool of those eligible to serve as crew members. Findings could also lead to improvements in diabetes monitoring and care in remote areas on Earth. "If we demonstrate that we can share data between a subject's glucose monitor in orbit and a physician on the ground in near real time, that could be implemented in a telemedicine setting with a clinician serving remote or austere locations on Earth," Rubin said. "If it can work in space, it could work on an oil rig, for example." We have come a long way in monitoring and treating diabetes, Rubin said. "There was a time where there was the perception that people with the disease couldn't do certain things. Today, you can play in the NFL, you can race cars, you can do all sorts of things that may have been difficult before. It only makes sense that the next barrier we break is human spaceflight." Ax-4 is scheduled to launch no earlier than June 10, 2025, at 8:22 a.m. EDT, from Florida. For additional information on ISS National Lab-sponsored investigations launching on Ax-4, visit our launch page. Download a high-resolution image for this release: Axiom Mission 4 Crew About the International Space Station (ISS) National Laboratory:The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Space® (CASIS®) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website. As a 501(c)(3) nonprofit organization, CASIS accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page. Media Contact: Patrick O'Neill904-806-0035 PONeill@ International Space Station (ISS) National Laboratory Managed by the Center for the Advancement of Science in Space® (CASIS®) 1005 Viera Blvd., Suite 101, Rockledge, FL 32955 • 321.253.5101 • View original content to download multimedia: SOURCE International Space Station National Lab

Whitening without the pain: Sensodyne Clinical White gives Canadians a reason to smile
Whitening without the pain: Sensodyne Clinical White gives Canadians a reason to smile

Yahoo

time26-05-2025

  • Yahoo

Whitening without the pain: Sensodyne Clinical White gives Canadians a reason to smile

Sensodyne launches new premium Clinical White toothpaste to brighten Canadians' smiles in time for National Smile Day. Toronto, ON, May 26, 2025 (GLOBE NEWSWIRE) -- With National Smile Day around the corner, new research from Sensodyne, the #1 dentist-recommended brand for sensitive teeth, reveals that more than 80 per cent of Canadians want whiter teeth, but for many, sensitivity and cost are standing in the way. The recent survey in partnership with Harris Poll, showed that 40 per cent have resorted to TikTok trend alternatives like baking soda, activated charcoal and oil pulling to get the results they want, but these often come at a painful cost: nearly half (46 per cent) of users report increased sensitivity. Despite widespread awareness of dentist-administered whitening treatments, only a quarter (26 per cent) of Canadians have tried them, citing concerns around cost and tooth sensitivity. These findings underscore what Canadians are truly seeking: an affordable, convenient, and sensitivity-friendly way to restore brilliance to their pearly whites – especially in time for Smile Day. 'We know Canadians are eager to brighten their smiles, but too often, they're left choosing between results and comfort,' says Dr. Derek Chung, dentist and founder of Paste Dental. 'That's why innovations like Sensodyne Clinical White are game changers – they can deliver effective whitening while also protecting sensitive teeth. It's a safe way to achieve a radiant smile with less risk.' A brighter smile with no sensitivity According to the survey, sensitivity is the top barrier to whitening, with one in five Canadians reporting tooth sensitivity as the primary inconvenience when whitening. To turn these frowns upside down, Sensodyne has released its new, premium Clinical White toothpaste. Scientifically developed and clinically proven to whiten teeth up to two shades whiter,[1] Clinical White offers 24/7 sensitivity protection in an enamel-safe formula. Free from hydrogen peroxide, a trigger that may cause sensitivity, it lifts stains in hard-to-reach places, polishes for a smoother, shinier finish, and helps prevent future staining. With National Smile Day taking place this Saturday, May 31, Sensodyne's Clinical White arrives just in time offering an affordable, effective solution for those seeking a brighter smile without the pain. Gentle enough for daily use, it's the perfect companion for coffee lovers, red wine enthusiasts, and anyone who wants to smile with confidence, because people shouldn't have to choose between a white smile and a comfortable one. Now available at major retailers across the country. For more information visit [1] Compared with a regular toothpaste after 8 weeks of twice daily brushing. About Haleon Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories: Oral Health; Vitamins, Minerals and Supplements (VMS); Pain Relief; Respiratory Health; Digestive Health; and Therapeutic Skin Health and Other. Built on trusted science, innovation and deep human understanding, Haleon Canada brands include Advil, Buckley's, Centrum, Emergen-C, Flonase, NeoCitran, Nexium, Polident, Robitussin, Sensodyne, TUMS, Voltaren and more. For more information on Haleon and its brands visit About Harris Poll The Harris Poll Canada is part of a full-service, global market research and consulting firm. We provide Canadian companies with accurate and trusted information to make key organizational decisions, avoid risk, and maximize growth. We are differentiated by decades of expertise in brand and reputation management, leadership from senior practitioners with over 20 years of experience, and our ability to activate results for meaningful impact. Visit CONTACT: Corporate Affairs, Haleon Canada Haleon Canada mediacanada@

Ken Paxton's Fluoride Toothpaste Conspiracy
Ken Paxton's Fluoride Toothpaste Conspiracy

Wall Street Journal

time15-05-2025

  • Wall Street Journal

Ken Paxton's Fluoride Toothpaste Conspiracy

It's harder to tell the difference these days between Republicans and left-wing Democrats. Take Ken Paxton, the Texas Attorney General and Senate candidate whose idea of a good government cause is to sue . . . toothpaste makers. Mr. Paxton said last week he is investigating Colgate-Palmolive Co., which makes the Colgate brand paste, and Procter & Gamble, which makes Crest. Their offense? He says they've been 'marketing toothpaste products to parents and children in ways that are misleading, deceptive, and dangerous.' He's out to nail what he thinks is the vast fluoride toothpaste conspiracy. Mr. Paxton claims there is a 'statistically significant association' between children who ingested too much fluoride and lower IQ scores. He says the Centers for Disease Control and Prevention recommends only a 'rice-sized 'smear'' for three-years old and the American Dental Association (ADA) recommends 'no more than a pea-sized amount' for children between three and six. Guess who else endorses the pea-sized amount? The toothpaste sellers, who put the same recommendation clear as day on their children's toothpaste labels. The label on Crest Kids toothpaste says 'use a pea-sized amount in children under 6.' Mr. Paxton says he must act to ensure the toothpaste makers are not 'putting Texas families in peril through their false, misleading, and deceptive marketing.' But the CDC website says fluoride 'helps both children and adults prevent cavities.' The addition of fluoride to drinking water since 1962 is '1 of 10 great public health achievements of the 20th century.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store